Watson-Marlow Fluid Technology Group presenting complete bioprocessing fluid path showcase at INTERPHEX 2018
Visit Booth 2833 to see how Watson-Marlow Fluid Technology Group is able to work with you at every process step...
List view / Grid view
Visit Booth 2833 to see how Watson-Marlow Fluid Technology Group is able to work with you at every process step...
A pilot study has found that whole genome sequencing of healthy individuals and cardiology patients did not increase health care spending outside of the sequencing costs.
Kaiser Optical Systems provides Raman analysers and fibre-optic probes for pharmaceutical applications ranging from laboratory discoveries to process control. Working with Kaiser is an opportunity to benefit from its experience and knowledge in Raman spectroscopy, chemometric model development, bioprocessing and pharmaceutical analysis.
In this edition, two leading analytical equipment suppliers explain how their products meet current industry requirements.
In this issue: DNA microarray for detecting, identifying and determining antimicrobial-resistant bacteria; the advantages of single-use technology and a framework for an implementation strategy; risk management when designing chemical safety assessments for pharmaceutical packaging systems.
A technique which allows the continuous production and collection of a cell has been developed removing the limit on the number of cells that can be grown in a culture dish...
NEWARK, Del. – W.L. Gore & Associates, Inc. (“Gore”), a global materials science company, will introduce its new GORE™ ImproJect™ Plunger at Pharmapack 2018, Europe's dedicated pharmaceutical packaging and drug delivery event. Gore will be in Booth A12 at the exhibition, to be held February 7 and 8, 2018, at…
Bottmingen, The latest version of eve® can integrate with a wide range of third-party bioreactors and equipment from a number of different suppliers, e.g. Sartorius DCU, Applikon or Matlab...
Production of protein therapeutics by mammalian cells is the most widely used bioprocess because of its ability to properly produce and fold a recombinant protein...
This In-Depth Focus looks at QbD and PAT for cutting biopharma attrition rates as well as continuous freeze-drying technology for biopharma products...
Adoption of Quality by Design (QbD) principles, regulatory support of QbD, process analytical technology (PAT), and continuous manufacturing are major factors effecting new approaches to pharmaceutical manufacturing and bioprocessing...
QbD and PAT could revolutionise the way biopharma industries operate by cutting down their attrition rates, which could drastically change their business model. This article considers the issues involved.
The work presented here investigates the development and application of new bioprocess analytics in accordance with the aims of QbD...
When the United States Food and Drug Administration (FDA) called for a shakeup of pharmaceutical production in 2002 it recommended the early adoption of technological advances and the application of modern quality management techniques. It believed that this would make manufacturing processes more robust and improve product quality.1
EvaluateMedTech World Preview provides a range of insights into the expected performance of the medtech industry...